Genomics Market Insights :
Genomics Market is projected to be worth USD 70.75 Billion by 2030, registering a CAGR of 15.2% during the forecast period (2022-2030), the market was valued at USD 19.80 Billion in 2021. The products segment dominated the genomics market with a 67.2% sales share in 2021. Real-time PCR is the most profitable income generator in genomics. Real-time quantitative PCR plays a key role in the absolute measurement of genetic components in genomic DNA. North America dominated the genomics market with a 36.7% share in 2020 in the regional segment, owing to a growth in the number of research programs, a high number of strategic alliances.
Genomics Market Dynamics:
Genomics is the study of the DNA with genes in a person or other organism. A complete set of genomes are present in each cell of an individual’s body. The genome contains all the information needed for a person to develop and grow.
Driver:
Increasing government initiatives and genome projects are fueling the growth of the genomics market. For instance, in 2020, the “Genome India Project” (GIP) was initiated by the Department of Biotechnology (DBT). The project’s main focus was on rare genetic disorders, precision health, complex diseases in the Indian population, mutation spectrum of genetics, and translational research.
Restraint:
High investment in research and a lack of skilled professional to handle sophisticated instruments is expected to hamper the growth of the genomics market.
Opportunity:
The surge in genomics research activities and massive demand for sequencing products is expected to create opportunities for the genomics market. Further, demand for personalized medicines and the use of genomics is anticipated to boost the growth opportunities for the market.
COVID-19 Analysis of Genomics Market:
The genomics market has been significantly impacted due to the covid-19 pandemic in many different parts of the world. Shipments were impacted during the initial lockdown due to a labor shortage and the closure of a manufacturing facility. The pandemic’s initial effects in China were tremendous. However, the nation’s circumstances have stabilized, and all product and service production rates have increased. As a result, it is determined that covid-19’s overall impact on the genomics market is moderate. Post covid-19 there was a positive impact on the genomics market as consumers were more focused on health, which increased the demand for the genomics market.
Genomics Report Coverage:
| Report Attributes | Report Details |
| Study Timeline | 2016-2030 |
| Market Size in 2030 (USD Billion) | 70.75 |
| CAGR (2022-2030) | 15.2% |
| By Deliverable | Products – Instruments/Systems/Software, Consumables & Reagents
Services – NGS-based Services, Core Genomics Services, End Use Translation Services, Computational Services, Others |
| By Application | Functional Genomics – Real-time PCR, Transfection, SNP Analysis, Mutational Analysis, Microarray Analysis, RNA Interference
Pathway Analysis – Microarray Analysis, Bead-based Analysis, Proteomics Tools (2-D PAGE; yeast 2-hybrid studies), Real-time PCR End Use Discovery – DNA Sequencing, Microarray Analysis, Real-time PCR, Mass Spectrometry, Statistical Analysis, Bioinformatics Epigenetics – Bisulfite Sequencing, Microarray Analysis, Chromatin Immunoprecipitation (ChIP & ChIP-Seq), Methylated DNA Immunoprecipitation (MeDIP), High Resolution Melt (HRM), Chromatin Accessibility Assays & Others |
| By End Use | Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Academic and Government Institutes, Clinical Research, Other End Users |
| By geography | North America– (U.S., Canada, Mexico
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA) |
| Key Players | Thermo Fisher Scientific, Inc.; Agilent Technologies; Beijing Genomics Institute (BGI); Bio-Rad Laboratories; Danaher Corporation; F. Hoffmann-La Roche Ltd.; GE Healthcare; Illumina, Inc.; Oxford Nanopore Technologies; Pacific Biosciences of California, Inc.; QIAGEN N.V.; Quest diagnostics; Myriad Genetics, Inc.; Eppendorf AG; Eurofins Scientific; Color; 23andMe, Inc. |
Genomics Market Segment Analysis:
By Deliverable
The deliverable segment includes products and services. The products segment dominated the genomics market with a 67.2% sales share in 2021. The continuous launch of nucleic acid extraction kits and reagents by prominent key players is boosting revenue generation in the category. For instance, Omega Bio-tek, Inc. launched a reliable and quick Mag-Bind Viral RNA Xpress Kit for viral RNA isolation from nasopharyngeal swab samples in 2020. This new kit was launched to address the lack of purification kits for RNA used in COVID-19 testing. Also, PHASE Scientific proclaimed the worldwide availability of the PHASIFY VIRAL RNA Extraction Kit in April 2020, for the identification and management of coronavirus. This kit enables the purification and concentration of viral nucleic acid in patient Viral Transport Media (VTM) samples. Similarly, QIAGEN NV declared the upcoming release of a unique kit to streamline and speed the PCR-based investigation of RNA-based viruses and COVID-19 (October 2020). Such developments in the product portfolio are expected to supplement the market’s organic revenue creation.
By Application
In 2020, functional genomics had the greatest revenue share of 33.2% in the application segment of genomics market. Real-time PCR is the most profitable income generator in genomics. Real-time quantitative PCR plays a key role in the absolute measurement of genetic components in genomic DNA. The approach has been used to examine the usage of tissue genomic DNA as a universal external standard for speeding the measurement of any target sequence in the genomes of multiple creatures. The application of this method in conjunction with reverse transcription PCR permits researchers to assess comparative gene expression at a specific time. As this approach is more sensitive than array technology at detecting minor changes in gene expression. Hence, the above-mentioned factors are driving the application segment in the genomics market.
By End Use
Pharmaceutical and biotechnology businesses owned 61.3% of the genomics market in 2020. As to the growing number of genetic research investigations, genomic technologies are in great demand from the pharmaceutical and biotechnology industries. Pharmaceutical companies are using genomic approaches to help ease and enhance the process as genomics plays important role in drug discovery and development. Personal genomics firms are producing genomes data to sell to pharmaceutical corporations. Moreover, to satisfy the increased demand for genomics services, numerous new firms have joined the market, owing to the ease of data analysis and the availability of lower-cost data capture. Hence, above mentioned factors are expected to fuel the growth of the genomics market.
By Region
North America dominated the genomics market with a 36.7% share in 2020 in the regional segment, owing to a growth in the number of research programs, a high number of strategic alliances, and an increase in regulatory approvals by the United States Food and Drug Administration. Changing reimbursement and usage laws are expected to accelerate the uptake of genetic testing in this region. Color Genomics, Inc., in conjunction with NorthShore University Health System, completed clinical genomics in regular care delivery under its U.S. program in January 2020. Imagenetics, a genomics initiative at Sanford, has also received assistance from the firm. Hence, the above-mentioned approvals are driving the growth of regional market in North America.
Genomics Market Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), product innovation, various business strategies, and product launches have accelerated the growth of the Genomics market. Key players in the market include-
- Thermo Fisher Scientific, Inc.
- Agilent Technologies
- Beijing Genomics Institute (BGI)
- Bio-Rad Laboratories
- Danaher Corporation
- Hoffmann-La Roche Ltd.
- GE Healthcare
- Illumina, Inc.
- Oxford Nanopore Technologies
- Pacific Biosciences of California, Inc.
- QIAGEN N.V.
- Quest diagnostics
- Myriad Genetics, Inc.
- Eppendorf AG
- Eurofins Scientific
- Color
- 23andMe, Inc.
Table of Content
- Introduction
- Market Introduction
- Market Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Limitations of the Study
- Product Picture of Genomics
- Global Genomics Market: Classification
- Geographic Scope
- Years Considered for the Study
- Research Methodology in brief
- Parent Market Overview
- Overall Genomics Market Regional Demand
- Research Programs/Design
- Market Breakdown and Data Triangulation Approach
- Data Source
- Secondary Sources
- Primary Sources
- Primary Interviews
- Average primary breakdown ratio
- Market Dynamics
- Drivers
- Drivers
- Restraints
- Restraints
- Opportunity
- Impact forces on market dynamics
- Impact forces during the forecast years
- Industry Value Chain
- Upstream analysis
- Downstream analysis
- Distribution Channel
- Direct Channel
- Indirect Channel
- Potential Customers
- Manufacturing/Operational Cost Analysis
- Pricing Analysis by Region
- Key Deliverable Landscape
- Regulatory Analysis
- Porter’s Analysis
- Supplier Power
- Buyer Power
- Substitution Threat
- Threat from New Entry
- Competitive Rivalry
- PESTEL Analysis
- Political Factors
- Economic Factor
- Social Factors
- Technological Factor
- Environmental Factors
- Legal Factor
- Covid-19 impact on Global Economy
- Covid-19 impact on Genomics demand
- Post-Covid Impact on Genomics Market Demand
- Impact Analysis of Russia-Ukraine Conflict
- Drivers
- Global Genomics Market Segmentation, by Revenue (USD Billion), (2022-2030)
- By Deliverable
- Products
- Instruments/Systems/Software
- Consumables & Reagents
- Services
- NGS-based Services
- Core Genomics Services
- Biomarker Translation Services
- Computational Services
- Others
- By Application
- Functional Genomics
- Real-time PCR
- Transfection
- SNP Analysis
- Mutational Analysis
- Microarray Analysis
- RNA Interference
- Pathway Analysis
- Microarray Analysis
- Bead-based Analysis
- Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
- Real-time PCR
- Biomarker Discovery
- DNA Sequencing
- Microarray Analysis
- Real-time PCR
- Mass Spectrometry
- Statistical Analysis
- Bioinformatics
- Epigenetics
- Bisulfite Sequencing
- Microarray Analysis
- Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
- Methylated DNA Immunoprecipitation (MeDIP)
- High Resolution Melt (HRM)
- Chromatin Accessibility Assays
- Others
- Functional Genomics
- By End Uses
- Circulating Nucleic Acids
- CTC
- Exosomes/Microvesicles
- Circulating Proteins
- Products
- By Deliverable
- Global Genomics Market Overview, By Region
- North America Genomics Market Revenue (USD Billion), by Countries, (2022-2030)
- US
- By Deliverable
- By Application
- By End Uses
- Canada
- Mexico
- US
- Europe Genomics Market Revenue (USD Billion), by Countries, (2022-2030)
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Asia Pacific Genomics Market Revenue (USD Billion), by Countries, (2022-2030)
- China
- Japan
- Australia
- South Korea
- India
- ASEAN
- North America Genomics Market Revenue (USD Billion), by Countries, (2022-2030)
- Latin America Genomics Market Revenue (USD Billion), by Countries, (2022-2030)
- Brazil
- Argentina
- Chile
- Middle East and Africa Genomics Market Revenue (USD Billion), by Countries, (2022-2030)
- GCC
- Turkey
- South Africa
- Global Genomics Market Revenue: Competitive Analysis, 2021
- Key strategies by players
- Revenue (USD Billion and %), By manufacturers, 2021
- Player Positioning by Market Players, 2021
- Competitive Analysis
- QIAGEN
- Business Overview
- Business Financials (USD billion)
- Product Category, Type, and Specification
- Main Business/Business Overview
- Geographical Analysis
- Recent Development
- Swot Analysis
- Thermo Fisher Scientific, Inc.
- Agilent Technologies
- Beijing Genomics Institute (BGI)
- Bio-Rad Laboratories
- Danaher Corporation
- Hoffmann-La Roche Ltd.
- GE Healthcare
- Illumina, Inc.
- Oxford Nanopore Technologies
- Pacific Biosciences of California, Inc.
- Quest diagnostics
- Myriad Genetics, Inc.
- Eppendorf AG
- Eurofins Scientific
- Color
- 23andMe, Inc.
- QIAGEN
- Market Research Findings & Conclusion
Disclaimer
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.